Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bill Steering Hemp In Supplements To NDI Notification Pathway Introduced For Third Time

Mar 17 2023

• By Malcolm Spicer

Related Content

US FDA ‘Punt’ On Hemp Rulemaking Frustrates, Confuses Supplement Industry

Jan 27 2023

Is US Hemp Policy Heading For Farm Bill, Act III?

Jan 27 2023

FDA Road To Decision On Expanding CBD Uses Starts With Weighing Impact On Existing And Future Use As Drug

Jun 03 2019

CBD Regulation Bill Filed In US House Again; VMS In Pre-Tax Savings Accounts In First Senate Vote

Feb 05 2021

After US FDA Objects To CBD Safety As NDIs, Supplement Industry Responds, What Else Is New?

Aug 13 2021

With Data Coming Slowly On Cannabis, Hemp Ingredients, FDA Launches ‘Acceleration Plan’

Dec 08 2021

Additional Topics

International United States US States Cannabidiol CBD FDA Legislation Business Strategies Commercial Compliance Consumer Dietary Supplements Cosmetics Enforcement Ingredients Manufacturing Lobbying Policy Politics Regulation Retail Safety Supply Chain

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window